Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
03/2012
03/06/2012US8128922 Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigen
03/06/2012US8128921 Use of conditional plasmodium strains lacking nutrient transporters in malaria vaccination
03/06/2012CA2506617C Colon cancer metastasis inhibitor
03/06/2012CA2487734C Treatment with cytokines for alzheimer's disease
03/06/2012CA2483707C Microparticles bearing cells and active substances
03/06/2012CA2445664C Use of il-18 inhibitors for treating or preventing cns injuries
03/01/2012WO2012027727A2 Lipomacrocycles and uses thereof
03/01/2012WO2012027713A2 Compositions and methods for inhibition of snca
03/01/2012WO2012027611A2 INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF TYROSYL-tRNA SYNTHETASES
03/01/2012WO2012027601A2 Methods targeting mir-33 micrornas for regulating lipid metabolism
03/01/2012WO2012027558A2 OPTIMIZED miRNA CONSTRUCTS
03/01/2012WO2012027555A2 Glycated cd59 peptides, their preparation, and uses thereof
03/01/2012WO2012027486A2 Methods and compositions for generation of induced pluripotent stem cells by rnaa
03/01/2012WO2012027462A2 Compositions and methods for treating neoplasia
03/01/2012WO2012027389A2 Mechanically-activated cation channels
03/01/2012WO2012025055A1 Methods and kits for predicting the risk of diabetes associated complications using genetic markers and arrays
03/01/2012WO2011143640A3 Treatment of par4 related diseases by inhibition of natural antisense transcript to par4
03/01/2012WO2011142798A3 Methods of preparing targeted aptamer prodrugs
03/01/2012WO2003002067A3 Inhibition of tumor growth and metastasis by n5 gene
03/01/2012US20120053233 Gene transfer agent composition containing polyamidoamine dendron
03/01/2012US20120053228 Splice-region antisense composition and method
03/01/2012US20120052487 Methods and compositions for selecting sirna of improved functionality
03/01/2012US20120052084 Staphylococcus aureus proteins and nucleic acids
03/01/2012US20120052044 Uses of mammalian cytokine; related reagents
02/2012
02/29/2012EP2423311A1 Method for preparing cell pharmaceutical
02/29/2012EP2423310A1 Cancer antigen helper peptide
02/29/2012EP2422819A2 Compositions and their uses directed to Huntingtin
02/29/2012EP2421967A2 Compositions, kits and methods for promoting ischemic and diabetic wound healing
02/29/2012EP2421563A1 Innate immune suppression enables repeated delivery of long rna molecules
02/29/2012EP2421542A1 Foamyvirus vectors and methods of use
02/29/2012EP2395085A9 Small interference rna complex with increased intracellular transmission capacity
02/29/2012EP2368989A9 Oligoribonucleotide or peptide nucleic acid capable of inhibiting activity of hepatitis c virus
02/29/2012EP2040719B1 Use of cells derived from adipose tissue for the preparation of an anti-tumour medicament
02/29/2012EP1941060B1 Protein demethylases comprising a jmjc domain
02/29/2012EP1625850B1 Immunostimulating agents
02/29/2012EP1390383B1 Antisense permeation enhancers
02/29/2012EP1002091B1 Nucleic acid sequence and method for selectively expressing a protein in a target cell or tissue
02/29/2012CN1884301B Targeted function superantigen and its preparation method and use
02/29/2012CN1351656B Human liver progenitors
02/29/2012CN102365112A Compositions for the treatment of gluten intolerance and uses thereof
02/29/2012CN102363780A Targeted human CD147 small molecule RNA interference sequence and use thereof
02/29/2012CN102362861A Hollow composite nanoparticle with core-shell structure and preparation method thereof
02/29/2012CN101880677B siRNA sequence against 2009 new influenza A virus polymerase gene and nucleoprotein gene and application thereof
02/29/2012CN101857860B Application of viral nucleic acid sequence strictly conservative area as siRNA design template
02/28/2012US8124753 Compositions and methods for inhibiting translation of a Mect1-MAML2 chimeric gene
02/28/2012US8124741 Antibodies to tumor associated proteins
02/28/2012US8124728 CA125 gene and its use for diagnostic and therapeutic interventions
02/28/2012US8124723 Circovirus sequences associated with piglet weight loss disease (PWD)
02/28/2012US8124592 Development of a preventive vaccine for filovirus infection in primates
02/28/2012US8124590 Biodegradable immunomodulatory formulations and methods for use thereof
02/28/2012US8124407 Circular nucleic acid vectors, and methods for making and using the same
02/28/2012US8124128 For delivery of water insoluble drugs, growth factors, genes, or cosmetic substances; biocompatible and biodegradable
02/28/2012US8124120 Preparing and using crosslinked, water insoluble, hydrated hyaluronic acid gel particles; in vivo biostability and mechanical properties, usability; ease of injection through fine needles
02/28/2012US8124105 Compositions, methods and kits relating to poxvirus subunit vaccines
02/28/2012US8124099 Soluble CD83 proteins and use thereof for the treatment and prevention of a disease or medical condition caused by dysfunction or undesired function of a cellular immune response involving T cells
02/28/2012US8124081 Using amyloid A specific immunoglobulin for use in prevention and treatment of infection, nervous system, cell proliferative and inflammatory disorders
02/28/2012US8124053 Compositions comprising chitin microparticles and their medical uses
02/28/2012CA2500215C Nucleic acid coated particles
02/28/2012CA2485506C A method for in vitro molecular evolution of protein function
02/28/2012CA2392202C Constructs for delivery of therapeutic agents to neuronal cells
02/23/2012WO2012024535A2 Methods for determining the presence or risk of developing facioscapulohumeral dystrophy (fshd)
02/23/2012WO2012024526A2 Conjugates, particles, compositions, and related methods
02/23/2012WO2012024478A2 Treatment of nicotinamide phosphoribosyltransferase (nampt) related diseases by inhibition of natural antisense transcript to nampt
02/23/2012WO2012024396A2 Compositions and methods for delivering nucleic acid molecules and treating cancer
02/23/2012WO2012024350A2 Anti-cancer adenoviruses
02/23/2012WO2012024309A2 Atherosclerosis inhibition via modulation of monocyte-macrophage phenotype using apo a-i milano gene transfer
02/23/2012WO2012024283A2 Universal influenza a vaccines
02/23/2012WO2012024170A2 RNA INTERFERENCE MEDIATED INHIBITION OF HEPATITIS B VIRUS (HBV) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
02/23/2012WO2012023995A1 Modification of recombinant adenovirus capsid protein with immunogenic plasmodium circumsporozoite protein epitopes
02/23/2012WO2012023622A1 Reagent for tumor testing and pharmaceutical composition for tumor prevention
02/23/2012WO2012023588A1 Diagnostic marker for malignant melanoma, pharmaceutical composition containing substance suppressing function of histatin-1 protein, and immunosuppressive agent
02/23/2012WO2012023291A1 Pharmaceutical composition for transcolonic absorption
02/23/2012WO2012023288A1 Fam161a as a target gene for cancer therapy and diagnosis
02/23/2012WO2012023286A1 Lrrc42 as a target gene for cancer therapy and diagnosis
02/23/2012WO2012023285A1 Ehmt2 as a target gene for cancer therapy and diagnosis
02/23/2012WO2012023259A1 C6orf167 as a target gene for cancer therapy and diagnosis
02/23/2012WO2012022040A1 Hiv-1 virus membrane fusion inhibitor and use thereof
02/23/2012WO2012021922A1 Particulate substances comprising ceramic particles for delivery of biomolecules
02/23/2012WO2011109677A3 Methods of increasing macropinocytosis in cancer cells
02/23/2012US20120047589 Method of delivery of nucleic acids to a developing embryo
02/23/2012US20120046349 Compositions for targeting conducting airway cells comprising adeno-associated virus constructs
02/23/2012US20120046347 Expression of apoai and variants thereof using spliceosome mediated rna trans-splicing
02/23/2012US20120046346 Sustained polypeptide expression from synthetic, modified rnas and uses thereof
02/23/2012US20120045501 Connexin enhances chemotherapy-included apoptosis in human cancer cells inhibiting tumor cell proliferation
02/23/2012US20120045452 Mnk KINASE HOMOLOGOUS PROTEINS INVOLVED IN THE REGULATION OF ENERGY HOMEOSTASIS AND ORGANELLE METABOLISM
02/23/2012US20120045451 Mnk KINASE HOMOLOGOUS PROTEINS INVOLVED IN THE REGULATION OF ENERGY HOMEOSTASIS AND ORGANELLE METABOLISM
02/23/2012US20120045447 T cell costimulating polypeptides and uses thereof
02/23/2012US20120045443 Agonist anti-trk-c monoclonal antibodies
02/23/2012US20120045389 Methods and reagents for efficient and targeted gene transfer to monocytes and macrophages
02/23/2012CA2808019A1 Particulate substances comprising ceramic particles for delivery of biomolecules
02/23/2012CA2807778A1 Anti-cancer adenoviruses
02/22/2012EP2420256A1 Gene therapy for neurometabolic disorders
02/22/2012EP2420247A1 Adenovirus formulations
02/22/2012EP2419535A1 Delivery of oligonucleotide-functionalized nanoparticles
02/22/2012EP2419145A2 Vertebral endplate connection implant and method
02/22/2012EP2419144A1 Composition for delivery of genetic material
02/22/2012EP2419143A1 Hpv particles and uses thereof
02/22/2012EP1633387B1 Combinations of tumor-associated antigens for the treatment of various types of cancers
02/22/2012EP1567007B1 Compositions and methods for cancer diagnosis and therapy
02/22/2012EP1255555B1 NON-MAMMALIAN GnRH ANALOG AND USES THEREOF IN REGULATING FERTILITY AND PREGNANCY
1 ... 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 ... 870